Bloomios, Inc. engages in the manufacture, market, and distribution of U.S. hemp-derived supplements and cosmetic products through wholesale distribution channels and its subsidiary. The company is headquartered in Santa Barbara, California. The company went IPO on 2003-10-14. BPL is engaged in manufacturing, processing, sourcing and distribution of hemp-derived, nootropic and nutraceutical products to wholesalers and retailers. BPL provides support at each step from custom formulation, order fulfilment, and brand development. The company offers its private-label and white-label customers large collections of customizable hemp products that include over 80 products across 10 categories in addition to custom formulation and manufacturing services. Its product categories include edibles, tinctures, oils, salves, capsules, balms, topicals, beverages and pet treats. The company manufactures hemp infused products ranging from human edibles, pet edibles, liquid consumables such as tinctures and shots, and topicals.
Follow-Up Questions
Who is the CEO of Bloomios Inc?
Mr. Michael Hill is the Chairman of the Board of Bloomios Inc, joining the firm since 2020.
What is the price performance of BLMS stock?
The current price of BLMS is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Bloomios Inc?
Bloomios Inc belongs to N/A industry and the sector is N/A
